ARYA Sciences Acquisition (ARYAU) Stock Price, News & Analysis

Company Overview

ARYA Sciences Acquisition Corp. was a special purpose acquisition company (SPAC) formed to identify and complete a business combination with a company operating in the life sciences sector. Rather than developing or marketing products itself, the company raised capital through its public offering and evaluated potential acquisition targets in biotechnology and related fields.

In 2020, ARYA Sciences Acquisition Corp. completed a business combination with Immatics Biotechnologies GmbH, a German biotechnology company focused on developing T-cell receptor-based therapies for cancer. Following the transaction, the combined company operated as Immatics N.V., while ARYA Sciences Acquisition Corp. ceased to function as an independent blank-check company. Immatics’ activities include the discovery and development of immunotherapies designed to target cancer-associated antigens.

ARYA Sciences Acquisition Corp. was sponsored by affiliates of Perceptive Advisors and was established with a focus on opportunities in the biotechnology and healthcare industries. Its principal geographic connection was to the United States through its formation and public listing, while the business combination brought together U.S. capital markets and Immatics’ research and development operations in Germany.

Key Stats

• Today's Range: $19.50 to $19.69
• 50-Day Range: $19.51 to $19.51
• 52-Week Range: $10.45 to $22.00
• Volume: 1,000 shs
• Average Volume: 6,785 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:ARYAU
• CIK: N/A
• Web: www.perceptivelife.com
• Phone: 212-284-2300
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A